Insights

Strategic Acquisition The recent acquisition of Labtec by AdhexPharma indicates increased investment in expanding the German market and integrating high-quality drug delivery solutions, presenting opportunities to offer complementary services or collaborative ventures focused on European expansion.

Market Focus Labtec's specialization in transdermal systems and oral films positions it as a key player in delivering patient-friendly pharmaceutical solutions, suggesting potential sales growth by providing innovations in formulation development, advanced manufacturing technologies, or regulatory consulting for these niche delivery systems.

Growth Potential With a revenue range of 1 million to 10 million USD and a focus on high-quality, full regulation-compliant production, there is an opportunity to introduce scalable manufacturing equipment, quality assurance software, or compliance solutions to support Labtec's growth trajectory.

Operational Synergies Labtec’s end-to-end drug development service offers a comprehensive platform for pharmaceutical clients, opening avenues to sell digital tools, supply chain management solutions, or innovative packaging technologies that enhance efficiency and patient experience.

Digital Enablement The company's tech stack including cloud-based systems and online presence signals a readiness for digital transformation; sales prospects include offering integrated IT solutions, data analytics, or cloud services to optimize R&D, manufacturing, and regulatory workflows.

Labtec Tech Stack

Labtec uses 8 technology products and services including Cloudflare CDN, RSS, WordPress, and more. Explore Labtec's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • RSS
    Content Management System
  • WordPress
    Content Management System
  • SAP
    Customer Relationship Management
  • React
    Javascript Frameworks
  • LinkedIn
    Online Community Software
  • X-Content-Type-Options
    Web & Portal Technology
  • Twitter
    Widgets

Labtec's Email Address Formats

Labtec uses at least 2 format(s):
Labtec Email FormatsExamplePercentage
First.Last@labtec-pharma.comJohn.Doe@labtec-pharma.com
100%
F.Last@adhexpharma.comJ.Doe@adhexpharma.com
99%
First.Last@adhexpharma.comJohn.Doe@adhexpharma.com
1%

Frequently Asked Questions

Where is Labtec's headquarters located?

Minus sign iconPlus sign icon
Labtec's main headquarters is located at 4 Raiffeisenstrasse Langenfeld, North Rhine-westphalia 40764 Germany. The company has employees across 4 continents, including EuropeSouth AmericaNorth America.

What is Labtec's stock symbol?

Minus sign iconPlus sign icon
Labtec is a publicly traded company; the company's stock symbol is DEVLAB.BO.

What is Labtec's official website and social media links?

Minus sign iconPlus sign icon
Labtec's official website is adhexpharma.com and has social profiles on LinkedIn.

What is Labtec's NAICS code?

Minus sign iconPlus sign icon
Labtec's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Labtec have currently?

Minus sign iconPlus sign icon
As of March 2026, Labtec has approximately 156 employees across 4 continents, including EuropeSouth AmericaNorth America. Key team members include Head Of Quality Management And Quality Assurance: D. D.Head Of Cmc And Head Of Corporate Qc: M. T.Senior Formulation Lab Manager / Senior Project Manager: S. A. A.. Explore Labtec's employee directory with LeadIQ.

What industry does Labtec belong to?

Minus sign iconPlus sign icon
Labtec operates in the Pharmaceutical Manufacturing industry.

What technology does Labtec use?

Minus sign iconPlus sign icon
Labtec's tech stack includes Cloudflare CDNRSSWordPressSAPReactLinkedInX-Content-Type-OptionsTwitter.

What is Labtec's email format?

Minus sign iconPlus sign icon
Labtec's email format typically follows the pattern of First.Last@labtec-pharma.com. Find more Labtec email formats with LeadIQ.

Labtec

Pharmaceutical ManufacturingNorth Rhine-westphalia, Germany51-200 Employees

By your side - from idea to market

We, Labtec, have a vast expertise as a full service CDMO for transdermal therapeutic systems and oral films. With almost 30 years of experience we develop innovative drug delivery systems that offer patients, medical professionals and caregivers reliable therapeutic efficacy with the highest level of convenience and comfort. Our customers are pharmaceutical companies all over the world and appreciate our high quality standards in devopment and manufacturing made in Germany.

As our customer, you may expect premium quality and full regulatory compliance. We allow you to reduce the number of contractors you currently work with and handle all steps of drug development and manufacturing.

As a B2B partner to the pharmaceutical industry, we offer end-to-end solutions for all stages of drug development:
from portfolio screening, development strategy, feasibility assessments, formulation development to clinical trial, production and packaging. We are your reliable partner and always by your side - from idea to market.

Section iconCompany Overview

Headquarters
4 Raiffeisenstrasse Langenfeld, North Rhine-westphalia 40764 Germany
Stock Symbol
DEVLAB.BO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Labtec's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Labtec's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.